Gefitinib has been reported to induce apoptosis in glioma cells by activating the pro-apoptotic protein Bad, with the ensuing mitochondrial translocation of Bax and the activation of caspase-9, which activates caspase-3 [214]. The gene discussed is CASP3; the disease is glioma.